Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Radiomics 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

senaparib 7 pembrolizumab 7 Irinotecan 6 Paclitaxel 5 Docetaxel 5 Cisplatin 5 Capecitabine 5 Nivolumab 4 Fluorouracil 4 Bevacizumab 4 Rifampin 3 Midazolam 3 Leucovorin 3 Itraconazole 3 Injections 3 pertuzumab 2 ontuxizumab 2 navoximod 2 atezolizumab 2 Gemcitabine 2 vofatamab 1 tremelimumab 1 trastuzumab duocarmazine 1 talazoparib 1 sotorasib 1 sintilimab 1 saracatinib 1 rucaparib 1 ridaforolimus 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor × Radiomics × Clear all

NCT04079283 2020-04-02

RIREP

Tianjin Medical University Cancer Institute and Hospital

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡